“…Bernard et al recently published a randomized controlled trial evaluating surgeon-administered TAP block with bupivacaine versus placebo in a similar patient population as this cohort of suspected or known gynecologic malignancy ( Bernard et al, 2023 ). Their data showed that surgeon-administered TAP block was not superior to placebo in reducing postoperative opioid requirement or improving postoperative outcomes.…”